|Bid||3.27 x 100|
|Ask||3.54 x 400|
|Day's Range||3.46 - 3.58|
|52 Week Range||2.83 - 7.14|
|PE Ratio (TTM)||-3.19|
|Earnings Date||Aug 2, 2017 - Aug 7, 2017|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||9.00|
Q1 2017 Merrimack Pharmaceuticals Inc Earnings Call
Merrimack Pharmaceuticals, Inc. (MACK) reported a loss of 22 cents per share in the first quarter of 2017, wider than the Zacks Consensus Estimate of a loss of 7 cents. The company had reported a loss of 32 cents in the year-ago quarter.
Merrimack reported a wider than expected first-quarter loss. The company reported a loss of 22 cents per share, wider than our consensus estimate of 7 cents.